Searching across hundreds of databases
Mitochondrial fusion and fission are critical to heart health; genetically interrupting either is rapidly lethal. To understand whether it is loss of, or the imbalance between, fusion and fission that underlies observed cardiac phenotypes, we engineered mice in which Mfn-mediated fusion and Drp1-mediated fission could be concomitantly abolished. Compared to fusion-defective Mfn1/Mfn2 cardiac knockout or fission-defective Drp1 cardiac knockout mice, Mfn1/Mfn2/Drp1 cardiac triple-knockout mice survived longer and manifested a unique pathological form of cardiac hypertrophy. Over time, however, combined abrogation of fission and fusion provoked massive progressive mitochondrial accumulation that severely distorted cardiomyocyte sarcomeric architecture. Mitochondrial biogenesis was not responsible for mitochondrial superabundance, whereas mitophagy was suppressed despite impaired mitochondrial proteostasis. Similar but milder defects were observed in aged hearts. Thus, cardiomyopathies linked to dynamic imbalance between fission and fusion are temporarily mitigated by forced mitochondrial adynamism at the cost of compromising mitochondrial quantity control and accelerating mitochondrial senescence.
Pubmed ID: 29107503 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG
View all literature mentionsThis polyclonal targets IgG
View all literature mentionsThis polyclonal targets LC3B
View all literature mentionsThis monoclonal targets LC3B (D11) XP Rabbit mAb
View all literature mentionsThis monoclonal targets CHOP
View all literature mentionsThis monoclonal targets Phospho-PERK (Thr980)
View all literature mentionsThis monoclonal targets PERK (C33E10) Rabbit mAb
View all literature mentionsThis monoclonal targets Calreticulin
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets Ubiquitin
View all literature mentionsThis polyclonal targets Afg3l2
View all literature mentionsThis monoclonal targets Tnnt2
View all literature mentionsThis polyclonal targets Superoxide Dismutase 2
View all literature mentionsThis polyclonal targets Superoxide Dismutase 1 antibody
View all literature mentionsThis monoclonal targets COX IV
View all literature mentionsThis polyclonal targets LC3A/B antibody
View all literature mentionsThis monoclonal targets SQSTM1 / p62
View all literature mentionsThis polyclonal targets Catalase - Peroxisome Marker
View all literature mentionsThis polyclonal targets LONP1 antibody
View all literature mentionsThis polyclonal targets Hsp60
View all literature mentionsThis polyclonal targets VDAC1
View all literature mentionsThis unknown targets OXPHOS
View all literature mentionsThis monoclonal targets GAPDH antibody [6C5]
View all literature mentionsThis polyclonal targets OPA1 antibody
View all literature mentionsThis monoclonal targets Mfn2
View all literature mentionsThis monoclonal targets MFF antibody [EPR7360]
View all literature mentionsThis monoclonal targets DNM1L
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
